Hair and nail disorders reveal far more than cosmetic concerns-they serve as windows into systemic disease, nutritional deficiencies, autoimmune processes, and genetic conditions that demand your diagnostic acumen. You'll master the molecular mechanisms driving these disorders, build pattern recognition skills to distinguish alopecia areata from tinea capitis or psoriatic nails from onychomycosis, and deploy evidence-based treatment algorithms that address both local pathology and underlying systemic triggers. By integrating dermatologic findings with multi-system clinical correlations, you'll transform subtle changes in keratin structures into actionable diagnoses that can alter patient outcomes.

📌 Remember: HAIRS - Hormones (androgens), Autoimmune (alopecia areata), Infections (tinea), Reactive (telogen effluvium), Scarring (lichen planopilaris). These five categories encompass >95% of hair loss presentations in clinical practice.
The diagnostic approach to hair and nail disorders demands systematic evaluation of growth patterns, morphological characteristics, and associated systemic findings. Master clinicians recognize that 80% of hair disorders present with characteristic patterns visible on clinical examination, while 20% require dermoscopy, trichoscopy, or histopathological confirmation.
⭐ Clinical Pearl: Hair pull tests yield >10 hairs in active telogen effluvium, <3 hairs in normal conditions, and 0-2 hairs in established androgenetic alopecia. This simple bedside test provides 85% diagnostic accuracy for differentiating acute versus chronic hair loss patterns.
Androgenetic Alopecia: Affects 50% of men by age 50, follows predictable Hamilton-Norwood patterns
Telogen Effluvium: Triggered 2-4 months after inciting event
Alopecia Areata: Autoimmune condition affecting 2% of population

💡 Master This: Nail growth rates vary by digit - thumbnails grow 3mm/month, fingernails 2.5mm/month, toenails 1mm/month. Complete nail replacement requires 6 months for fingernails, 12-18 months for toenails. Understanding these timelines predicts when therapeutic changes become visible and guides treatment duration expectations.
Connect these foundational patterns through systematic clinical evaluation to understand how morphological changes reveal underlying pathophysiology and guide targeted therapeutic interventions.
📌 Remember: CYCLES - Catagen (regression 2-3 weeks), Youth phase (anagen 2-7 years), Cessation (telogen 3 months), Length determines by anagen duration, Exogen (active shedding), Synchronization disruption causes effluvium. Normal follicles cycle independently; pathological conditions synchronize cycling patterns.
The androgenetic alopecia pathway demonstrates how 5α-reductase converts testosterone to DHT, which binds androgen receptors with 10-fold higher affinity than testosterone. This binding activates transcription factors that upregulate TGF-β1 expression by 300%, leading to follicular miniaturization over 20-25 cycles. Understanding this cascade explains why 5α-reductase inhibitors prevent 83% of further hair loss and why treatment requires 6-12 months to show visible results.
⭐ Clinical Pearl: Nail matrix cells divide every 12-24 hours, making nails sensitive indicators of systemic disease. Beau's lines appear 2-4 weeks after illness onset, with 1mm of nail growth representing approximately 1 month of time. This temporal relationship allows precise dating of systemic insults.
Autoimmune Mechanisms: Alopecia areata involves CD8+ T-cell infiltration around follicular bulbs
Infectious Pathophysiology: Dermatophyte invasion follows predictable patterns
💡 Master This: The hair follicle immune privilege depends on MHC class I downregulation and immunosuppressive factors like TGF-β and α-MSH. When this privilege collapses in alopecia areata, CD8+ T-cells recognize follicular antigens as foreign, creating the "swarm of bees" histological pattern around anagen bulbs.
| Pathway | Key Mediator | Timeline | Clinical Marker | Treatment Target |
|---|---|---|---|---|
| Androgenetic | DHT/AR complex | 2-5 years | Progressive thinning | 5α-reductase |
| Autoimmune | CD8+ T-cells | 2-6 months | Patchy loss | JAK inhibitors |
| Inflammatory | TNF-α/IL-1β | 1-3 months | Scarring | Immunosuppression |
| Infectious | Keratinases | 6-12 months | Nail dystrophy | Antifungals |
| Metabolic | Growth factors | 2-4 months | Diffuse thinning | Nutritional support |

📌 Remember: PATTERN - Progressive (androgenetic), Acute onset (telogen effluvium), Total loss (alopecia totalis), Terminal hair affected (androgenetic), Exclamation point hairs (alopecia areata), Receding hairline (male pattern), Nail changes (systemic disease). Each pattern points to specific diagnostic categories with >90% accuracy.
The systematic approach to hair loss evaluation follows a hierarchical decision tree that rapidly narrows differential diagnosis. Distribution pattern provides the first diagnostic clue: diffuse thinning suggests telogen effluvium or female pattern hair loss, patchy loss indicates alopecia areata or trichotillomania, scarring points to cicatricial alopecias, and patterned loss confirms androgenetic alopecia.
Androgenetic Alopecia Recognition Patterns:
Alopecia Areata Diagnostic Framework:

⭐ Clinical Pearl: The hair pull test provides 85% diagnostic accuracy when performed correctly. Extract 50-60 hairs from 3 different scalp areas using firm traction. Normal result: <3 hairs/pull. Positive test (>10 hairs) indicates active hair shedding phase, distinguishing telogen effluvium from androgenetic alopecia with high specificity.
💡 Master This: Dermoscopy magnification reveals diagnostic features invisible to naked eye examination. Yellow dots (empty follicular openings) indicate follicular destruction in alopecia areata. Peripilar signs (brown halos around follicles) suggest androgenetic alopecia. Black dots (broken hair shafts) point to trichotillomania or tinea capitis.
| Clinical Sign | Primary Association | Sensitivity | Specificity | Additional Features |
|---|---|---|---|---|
| Exclamation point hairs | Alopecia areata | 85% | 95% | 2-3mm length, tapered base |
| Yellow dots | Follicular destruction | 78% | 89% | Empty follicular openings |
| Geometric pitting | Alopecia areata | 44% | 92% | Uniform pit distribution |
| Christmas tree pattern | Female androgenetic | 76% | 88% | Central part widening |
| Ophiasis pattern | Severe alopecia areata | 12% | 98% | Band-like occipital loss |
📌 Remember: DIFFERS - Distribution (focal vs diffuse), Inflammation (present vs absent), Follicular involvement (scarring vs non-scarring), Family history (genetic vs acquired), Exacerbating factors (hormonal vs environmental), Recovery pattern (spontaneous vs progressive), Systemic associations (isolated vs multisystem). These seven parameters discriminate >95% of hair loss differentials.
The systematic approach to differential diagnosis employs quantitative discriminators that provide objective separation between overlapping conditions. Temporal patterns offer the first level of discrimination: acute onset (<6 months) suggests telogen effluvium or alopecia areata, gradual progression (>2 years) indicates androgenetic alopecia, and rapid progression (<3 months) points to severe systemic disease or cicatricial alopecia.
Telogen Effluvium vs Female Pattern Hair Loss:
Alopecia Areata vs Trichotillomania:

⭐ Clinical Pearl: Biopsy timing critically affects diagnostic accuracy. In suspected alopecia areata, biopsy active borders showing exclamation point hairs, not central bald areas. In cicatricial alopecia, target erythematous advancing edges where inflammation is most active. Proper site selection increases diagnostic yield from 60% to >90%.
💡 Master This: Laboratory correlation provides definitive discrimination when clinical features overlap. KOH examination has 80% sensitivity for onychomycosis but 95% specificity. Fungal culture requires 4-6 weeks but provides species identification and antifungal sensitivity. PCR testing offers 95% sensitivity with 48-hour results but costs 3-fold more than culture.
| Condition | Onset Pattern | Distribution | Hair Pull Test | Dermoscopy Findings | Recovery Pattern |
|---|---|---|---|---|---|
| Telogen Effluvium | Acute (2-4 months) | Diffuse uniform | >10 hairs | Uniform diameter | 6-12 months |
| Androgenetic Alopecia | Gradual (years) | Patterned | <3 hairs | >20% variation | Progressive |
| Alopecia Areata | Subacute (weeks) | Patchy round | Variable | Yellow/black dots | 80% in 1 year |
| Trichotillomania | Variable | Irregular patches | <5 hairs | Broken hairs | With behavior change |
| Tinea Capitis | Gradual (months) | Patchy with scale | >5 hairs | Comma hairs | With antifungals |

📌 Remember: THERAPY - Timing (early intervention improves outcomes), Hormonal status (affects drug selection), Efficacy data (evidence-based choices), Risk factors (contraindications), Adherence potential (realistic regimens), Patient preferences (lifestyle factors), Yield expectations (realistic goals). These seven factors determine treatment success rates and patient satisfaction.
The systematic approach to treatment selection employs evidence-based algorithms that match therapeutic mechanisms to disease pathophysiology. First-line therapies demonstrate >70% efficacy with acceptable safety profiles, second-line options target refractory cases or specific patient populations, and combination therapies achieve synergistic effects with 15-25% improved response rates over monotherapy.
Androgenetic Alopecia Treatment Algorithm:
Alopecia Areata Treatment Hierarchy:
⭐ Clinical Pearl: Treatment duration critically affects success rates. Androgenetic alopecia requires 6-12 months to show visible improvement, with maximum benefit at 24 months. Discontinuing therapy results in return to baseline within 12 months. Setting realistic expectations prevents premature treatment abandonment and improves long-term outcomes.
💡 Master This: Biomarker monitoring optimizes treatment outcomes and prevents adverse effects. DHT levels decrease 65% with finasteride, 90% with dutasteride. Liver function tests should be monitored with oral antifungals every 4-6 weeks. Complete blood counts are essential with JAK inhibitors due to immunosuppressive effects.
| Condition | First-Line Treatment | Response Rate | Time to Response | Maintenance Required | Alternative Options |
|---|---|---|---|---|---|
| Male AGA | Finasteride 1mg daily | 83% stabilization | 6-12 months | Continuous | Dutasteride, transplant |
| Female AGA | Minoxidil 5% BID | 60% improvement | 4-6 months | Continuous | Spironolactone, laser |
| Alopecia Areata | Intralesional steroids | 60-70% regrowth | 2-3 months | PRN | Topical immunotherapy |
| Onychomycosis | Terbinafine 250mg | 76% cure | 3-6 months | None | Itraconazole, topicals |
| Telogen Effluvium | Trigger removal | 90% recovery | 6-12 months | None | Minoxidil, supplements |
📌 Remember: SYSTEMS - Systemic lupus (diffuse hair loss), Yellow nail syndrome (lymphatic dysfunction), Sclerodactyly (nail fold changes), Thyroid disease (hair texture changes), Endocrine disorders (hirsutism patterns), Malnutrition (multiple deficiencies), Sarcoidal granulomas (scarring alopecia). These systemic associations guide comprehensive evaluation and reveal underlying pathophysiology.
The integration of hair and nail findings with systemic disease follows predictable patterns that enhance diagnostic accuracy and reveal disease activity. Autoimmune conditions affect hair and nails in 60-80% of cases, endocrine disorders create characteristic patterns in >90% of patients, and nutritional deficiencies manifest dermatologically before systemic symptoms in 70% of cases.
Endocrine-Hair Integration Patterns:
Autoimmune-Nail Correlations:

⭐ Clinical Pearl: Nail fold capillaroscopy reveals systemic autoimmune disease with 95% specificity. Giant capillary loops (>50 micrometers) indicate scleroderma spectrum disorders. Capillary dropout correlates with digital ulceration risk and pulmonary hypertension development. This simple office procedure provides systemic disease monitoring capabilities.
💡 Master This: Genetic syndromes create pathognomonic hair and nail patterns that enable early diagnosis. Pachyonychia congenita shows focal palmoplantar keratoderma with thick nails from birth. Ectodermal dysplasias combine sparse hair, absent teeth, and dystrophic nails. Monilethrix creates beaded hair shafts with regular constrictions every 0.7-1mm.
| System | Hair Manifestation | Nail Manifestation | Associated Findings | Diagnostic Test | Treatment Impact |
|---|---|---|---|---|---|
| Thyroid | Texture changes, thinning | Onycholysis, ridging | Weight, temperature changes | TSH, T3, T4 | Hormone replacement |
| Autoimmune | Patchy loss, scarring | Pitting, pterygium | Joint pain, rashes | ANA, specific antibodies | Immunosuppression |
| Nutritional | Diffuse thinning, brittle | Splitting, ridging | Fatigue, poor wound healing | Ferritin, B12, zinc | Targeted supplementation |
| Genetic | Structural abnormalities | Dystrophy from birth | Developmental anomalies | Genetic testing | Supportive care |
| Infectious | Inflammatory loss | Dystrophy, discoloration | Fever, lymphadenopathy | Culture, PCR | Antimicrobial therapy |
📌 Remember: RAPID - Recognize pattern (distribution/morphology), Assess timeline (acute vs chronic), Perform targeted tests (pull test/dermoscopy), Identify systemic clues (associated findings), Determine treatment urgency (progressive vs stable). This 5-step framework provides >85% diagnostic accuracy in <5 minutes of clinical evaluation.
⭐ Clinical Pearl: The 3-2-1 Rule for urgent referral: 3 months of rapid progression, 2 systems involved (hair + nails), 1 red flag sign (scarring, systemic symptoms, or treatment resistance). This framework identifies >95% of cases requiring immediate specialist evaluation or systemic workup.
💡 Master This: Pattern + Timeline + Response creates diagnostic certainty. Androgenetic alopecia shows patterned loss over years with poor response to anti-inflammatory treatments. Alopecia areata demonstrates patchy loss over months with variable spontaneous recovery. Telogen effluvium presents diffuse loss over weeks with excellent recovery after trigger removal.
| Clinical Tool | Diagnostic Target | Sensitivity | Specificity | Time Required | Clinical Utility |
|---|---|---|---|---|---|
| Hair Pull Test | Active shedding | 85% | 90% | 30 seconds | Telogen effluvium screening |
| Dermoscopy | Pattern recognition | 90% | 85% | 2 minutes | Differential diagnosis |
| Nail Examination | Systemic disease | 75% | 95% | 1 minute | Autoimmune screening |
| Timeline Analysis | Etiology classification | 80% | 88% | 30 seconds | Rapid triage |
| Family History | Genetic predisposition | 70% | 85% | 1 minute | Risk stratification |
Test your understanding with these related questions
Finasteride is classified as a:
Get full access to all lessons, practice questions, and more.
Start Your Free Trial